[Changes in cardiovascular reactivity related to the presence of a portacaval anastomosis in the dog].
D006916:5-Hydroxytryptophan / Q000494:pharmacology; D000818:Animals; D001285:Atropine / Q000494:pharmacology; D001337:Autonomic Agents / Q000494:pharmacology*; D002319:Cardiovascular System / Q000503:physiopathology*; D002395:Catecholamines / Q000494:pharmacology*; D004285:Dogs; D006145:Guanethidine / Q000494:pharmacology; D011167:Portacaval Shunt, Surgical / Q000009:adverse effects*; D014191:Tranylcypromine / Q000494:pharmacology
D001337:Autonomic Agents; D002395:Catecholamines; D014191:Tranylcypromine; D001285:Atropine; D006916:5-Hydroxytryptophan; D006145:Guanethidine
Modifications de la réactivité cardio-vasculaire liées à la présence d'une anastomose porto-cave chez le chien.